DM: Diabetes mellitus DM1: Diabetes mellitus type 1 – F/M: Female/Male
– No.: Number – NOP: number of patients
1. Naumowicz M, Modzelewski S, Macko A, Łuniewski B, Baran A, Flisiak I.
A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on
Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation.
International Journal of Molecular Sciences. 2024;25(6):3482.2.
Erfurt-Berge C, Heusinger V, Reinboldt-Jockenhöfer F, Dissemond J,
Renner R. Comorbidity and therapeutic approaches in patients with
necrobiosis lipoidica. Dermatology. 2022;238(1):148-55.3. Papara C, De
Luca DA, Bieber K, Vorobyev A, Ludwig RJ. Morphea: the 2023 update.
Frontiers in medicine. 2023;10:1108623.4. Acebo E, Gardeazábal J,
Marcellán M, Lasa O, Burgos JJ, Díaz-Pérez JL. Necrobiosis lipoidica
over appendectomy scar in a patient with morphea of the breast. Actas
Dermo-sifiliograficas. 2006;97(1):52-5.5. Severson KJ, Patel MH,
Brumfiel CM, Breen I, Butterfield RJ, Nelson SA, et al. Comorbidities
and diabetic complications in patients with necrobiosis lipoidica.
Journal of the American Academy of Dermatology. 2022;86(4):891-4.6.
Hashemi DA, Brown-Joel ZO, Tkachenko E, Nelson CA, Noe MH, Imadojemu S,
et al. Clinical features and comorbidities of patients with necrobiosis
lipoidica with or without diabetes. JAMA dermatology.
2019;155(4):455-9.7. Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P,
Kuhn A, et al. German guidelines for the diagnosis and therapy of
localized scleroderma. JDDG: Journal der Deutschen Dermatologischen
Gesellschaft. 2016;14(2):199-216.8. Jockenhöfer F, Kröger K, Klode J,
Renner R, Erfurt‐Berge C, Dissemond J. Cofactors and comorbidities of
necrobiosis lipoidica: analysis of the German DRG data from 2012. JDDG:
Journal der Deutschen Dermatologischen Gesellschaft.
2016;14(3):277-84.9. Erfurt-Berge C, Seitz A-T, Rehse C, Wollina U,
Schwede K, Renner R. Update on clinical and laboratory features in
necrobiosis lipoidica: a retrospective multicentre study of 52 patients.
European Journal of Dermatology. 2012;22(6):770-5.10. Marcoval J,
Gómez-Armayones S, Valentí-Medina F, Bonfill-Ortí M, Martínez-Molina L.
Necrobiosis lipoidica: a descriptive study of 35 cases. Actas
Dermo-Sifiliográficas (English Edition). 2015;106(5):402-7.11. MULLER
SA, Winkelmann R. Necrobiosis lipoidica diabeticorum: a clinical and
pathological investigation of 171 cases. Archives of Dermatology.
1966;93(3):272-81.12. Ionescu C, Petca A, Dumitrașcu MC, Petca R-C,
Ionescu AI, Șandru F. The Intersection of Dermatological Dilemmas and
Endocrinological Complexities: Understanding Necrobiosis Lipoidica—A
Comprehensive Review. Biomedicines. 2024;12(2):337.13. Heite H-J,
Scharwenka H. Erythema elevatum diutinum, Granuloma anulare, Necrobiosis
lipoidica und Granulomatosis disciformis Gottron-Miescher: Eine
vergleichende häufigkeitsanalytische Studie. Archiv für klinische und
experimentelle Dermatologie. 1959;208(3):260-90.14. O’toole E, Kennedy
U, Nolan J, Young M, Rogers S, Barnes L. Necrobiosis lipoidica: only a
minority of patients have diabetes mellitus. British Journal of
Dermatology. 1999;140(2):283-6.15. Erfurt-Berge C, Dissemond J, Schwede
K, Seitz A-T, Al Ghazal P, Wollina U, et al. Updated results of 100
patients on clinical features and therapeutic options in necrobiosis
lipoidica in a retrospective multicentre study. European Journal of
Dermatology. 2015;25:595-601.16. Hammer E, Lilienthal E, Hofer SE,
Schulz S, Bollow E, Holl R, et al. Risk factors for necrobiosis
lipoidica in Type 1 diabetes mellitus. Diabetic Medicine.
2017;34(1):86-92.